378 related articles for article (PubMed ID: 8567115)
1. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
Clark JW; Santos-Moore A; Stevenson LE; Frackelton AR
Int J Cancer; 1996 Jan; 65(2):186-91. PubMed ID: 8567115
[TBL] [Abstract][Full Text] [Related]
2. G protein beta gamma subunits stimulate phosphorylation of Shc adapter protein.
Touhara K; Hawes BE; van Biesen T; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9284-7. PubMed ID: 7568118
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways.
Chae HJ; Chae SW; Kang JS; Kim DE; Kim HR
Res Commun Mol Pathol Pharmacol; 1999; 105(3):185-99. PubMed ID: 10954125
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitogenic signaling by endothelin 1 in ovarian carcinoma cells.
Bagnato A; Tecce R; Di Castro V; Catt KJ
Cancer Res; 1997 Apr; 57(7):1306-11. PubMed ID: 9102218
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Ras signaling pathway by the CD40 receptor.
Gulbins E; Brenner B; Schlottmann K; Koppenhoefer U; Linderkamp O; Coggeshall KM; Lang F
J Immunol; 1996 Oct; 157(7):2844-50. PubMed ID: 8816388
[TBL] [Abstract][Full Text] [Related]
6. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
7. Transient activation of Ras-dependent signalling at the early stages of Herbimycin A induced erythroid differentiation of human K562 cells.
Drobot L; Husak Z; Ilnytska O; Igumentseva N; Oleksyn H; Kusen' S
Exp Oncol; 2005 Mar; 27(1):31-7. PubMed ID: 15812354
[TBL] [Abstract][Full Text] [Related]
8. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
Graber M; June CH; Samelson LE; Weiss A
Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473
[TBL] [Abstract][Full Text] [Related]
9. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
Rao YP; Buckley DJ; Buckley AR
Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of inorganic phosphate transport by insulin-like growth factor I and vanadate in opossum kidney cells is mediated by distinct protein tyrosine phosphorylation processes.
Palmer G; Bonjour JP; Caverzasio J
Endocrinology; 1996 Nov; 137(11):4699-705. PubMed ID: 8895336
[TBL] [Abstract][Full Text] [Related]
12. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation.
Chen K; Vita JA; Berk BC; Keaney JF
J Biol Chem; 2001 May; 276(19):16045-50. PubMed ID: 11278982
[TBL] [Abstract][Full Text] [Related]
13. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
[TBL] [Abstract][Full Text] [Related]
14. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases.
Rozakis-Adcock M; McGlade J; Mbamalu G; Pelicci G; Daly R; Li W; Batzer A; Thomas S; Brugge J; Pelicci PG; Schlessinger J; Pawson T
Nature; 1992 Dec; 360(6405):689-92. PubMed ID: 1465135
[TBL] [Abstract][Full Text] [Related]
15. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorylation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors.
Ralph SJ; Wines BD; Payne MJ; Grubb D; Hatzinisiriou I; Linnane AW; Devenish RJ
J Immunol; 1995 Mar; 154(5):2248-56. PubMed ID: 7532663
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 10 modulation of tumour necrosis factor receptors requires tyrosine kinases but not the PI 3-kinase/p70 S6 kinase pathway.
Williams L; Lali F; Clarke C; Brennan F; Foxwell B
Cytokine; 2000 Jul; 12(7):934-43. PubMed ID: 10880238
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
18. Ras is not required for the interleukin 3-induced proliferation of a mouse pro-B cell line, BaF3.
Terada K; Kaziro Y; Satoh T
J Biol Chem; 1995 Nov; 270(46):27880-6. PubMed ID: 7499262
[TBL] [Abstract][Full Text] [Related]
19. UCS15A, a non-kinase inhibitor of Src signal transduction.
Sharma SV; Oneyama C; Yamashita Y; Nakano H; Sugawara K; Hamada M; Kosaka N; Tamaoki T
Oncogene; 2001 Apr; 20(17):2068-79. PubMed ID: 11360191
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
Tari AM; Hung MC; Li K; Lopez-Berestein G
Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]